These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11834592)

  • 21. Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control.
    Shimoda-Matsubayashi S; Hattori T; Matsumine H; Shinohara A; Yoritaka A; Mori H; Kondo T; Chiba M; Mizuno Y
    Neurology; 1997 Nov; 49(5):1257-62. PubMed ID: 9371904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
    Adams JR; van Netten H; Schulzer M; Mak E; Mckenzie J; Strongosky A; Sossi V; Ruth TJ; Lee CS; Farrer M; Gasser T; Uitti RJ; Calne DB; Wszolek ZK; Stoessl AJ
    Brain; 2005 Dec; 128(Pt 12):2777-85. PubMed ID: 16081470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease.
    Harding AJ; Stimson E; Henderson JM; Halliday GM
    Brain; 2002 Nov; 125(Pt 11):2431-45. PubMed ID: 12390970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Western Nebraska family (family D) with autosomal dominant parkinsonism.
    Wszolek ZK; Pfeiffer B; Fulgham JR; Parisi JE; Thompson BM; Uitti RJ; Calne DB; Pfeiffer RF
    Neurology; 1995 Mar; 45(3 Pt 1):502-5. PubMed ID: 7898705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal cord lesions in sporadic Parkinson's disease.
    Del Tredici K; Braak H
    Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiology of sporadic Parkinson's disease].
    Braak H; Del Tredici K
    Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S2-4. PubMed ID: 20195936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptomic signatures of brain regional vulnerability to Parkinson's disease.
    Keo A; Mahfouz A; Ingrassia AMT; Meneboo JP; Villenet C; Mutez E; Comptdaer T; Lelieveldt BPF; Figeac M; Chartier-Harlin MC; van de Berg WDJ; van Hilten JJ; Reinders MJT
    Commun Biol; 2020 Mar; 3(1):101. PubMed ID: 32139796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study.
    Piccini P; Morrish PK; Turjanski N; Sawle GV; Burn DJ; Weeks RA; Mark MH; Maraganore DM; Lees AJ; Brooks DJ
    Ann Neurol; 1997 Feb; 41(2):222-9. PubMed ID: 9029071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease susceptibility variants and severity of Lewy body pathology.
    Heckman MG; Kasanuki K; Diehl NN; Koga S; Soto A; Murray ME; Dickson DW; Ross OA
    Parkinsonism Relat Disord; 2017 Nov; 44():79-84. PubMed ID: 28917824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease--a single clinical entity?
    Brooks DJ
    QJM; 1995 Feb; 88(2):81-91. PubMed ID: 7704567
    [No Abstract]   [Full Text] [Related]  

  • 34. Co-occurrence of essential tremor and Parkinson's disease: clinical study of a large kindred with autopsy findings.
    Yahr MD; Orosz D; Purohit DP
    Parkinsonism Relat Disord; 2003 Mar; 9(4):225-31. PubMed ID: 12618058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lewy bodies in Parkinson's disease: histological, immunohistochemical, and interferometric examinations].
    Voronkov DN; Salkov VN; Anufriev PL; Khudoerkov RM
    Arkh Patol; 2018; 80(4):9-13. PubMed ID: 30059066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation analysis of the neurofilament M gene in Parkinson's disease.
    Krüger R; Fischer C; Schulte T; Strauss KM; Müller T; Woitalla D; Berg D; Hungs M; Gobbele R; Berger K; Epplen JT; Riess O; Schöls L
    Neurosci Lett; 2003 Nov; 351(2):125-9. PubMed ID: 14583397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large French-Canadian family with Lewy body parkinsonism: exclusion of known loci.
    Grimes DA; Grimes JD; Racacho L; Scoggan KA; Han F; Schwarz BA; Woulfe J; Bulman D
    Mov Disord; 2002 Nov; 17(6):1205-12. PubMed ID: 12465058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.